Protagonist Therapeutics Inc Asset Turnover Ratio (PTGX), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Protagonist Therapeutics inc   (NASDAQ: PTGX)
 

Protagonist Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Protagonist Therapeutics Inc asset turnover ratio, the ability of Protagonist Therapeutics Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.38 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as PTGX's position remain challenging.

Within sector 111 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2545 to 2667.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PTGX Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 27.12 % -6.24 % -10.32 % 16.11 % 13.5 %
Y / Y Revenue Change 3749.17 % 99.03 % -95.64 % 0.79 % 33.09 %
Asset Turnover Ratio (TTM) 0.38 0.11 0.07 0.29 0.3
PTGX's Total Ranking # 2667 # 2545 # 10 # 2343 #
Seq. Asset Change 27.46 % 4.38 % -4.85 % 0.42 % -5.99 %
Seq. Revenue Change 278.72 % 657.94 % 57.83 % -15.04 % -80.42 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 112
Healthcare Sector # 372
Overall Market # 2667

Asset Turnover Ratio Statistics
High Average Low
185.28 22.13 -0.03
(Jun 30 2025)   (Sep 30 2019)




PTGX Company Profile • Back to PTGX Efficiency Comparisons • Compare PTGX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Ardelyx inc   0.87 $ 450.894  Millions$ 517.044  Millions
Atricure Inc   0.87 $ 567.747  Millions$ 652.563  Millions
Lensar Inc   0.87 $ 60.264  Millions$ 69.354  Millions
Encompass Health Corporation  0.86 $ 6,206.100  Millions$ 7,181.525  Millions
Regen Biopharma Inc   0.86 $ 0.237  Millions$ 0.274  Millions
Xeris Biopharma Holdings Inc   0.86 $ 335.414  Millions$ 389.409  Millions
Bioventus Inc   0.86 $ 581.106  Millions$ 677.259  Millions
Protalix Biotherapeutics inc   0.85 $ 80.619  Millions$ 94.321  Millions
Amneal Pharmaceuticals Inc   0.85 $ 3,117.474  Millions$ 3,648.680  Millions
Cytosorbents Corporation  0.85 $ 35.663  Millions$ 42.114  Millions
Vivos Therapeutics Inc   0.85 $ 21.135  Millions$ 24.996  Millions
Urogen Pharma Ltd   0.84 $ 188.317  Millions$ 222.945  Millions
Alpha Pro Tech Ltd   0.84 $ 62.204  Millions$ 74.083  Millions
Healthlynked Corp  0.82 $ 1.372  Millions$ 1.671  Millions
Adma Biologics Inc   0.80 $ 510.934  Millions$ 635.581  Millions
West Pharmaceutical Services Inc   0.80 $ 3,326.900  Millions$ 4,140.500  Millions
Irhythm Holdings Inc   0.80 $ 825.702  Millions$ 1,028.762  Millions
Davita Inc   0.80 $ 14,009.646  Millions$ 17,561.212  Millions
Airsculpt Technologies Inc   0.79 $ 150.724  Millions$ 189.626  Millions
Concentra Group Holdings Parent Inc   0.79 $ 2,287.465  Millions$ 2,900.588  Millions
Nexgel Inc   0.79 $ 11.810  Millions$ 15.032  Millions
Iradimed Corporation  0.76 $ 86.339  Millions$ 113.215  Millions
Lifeward ltd   0.76 $ 21.822  Millions$ 28.622  Millions
Msa Safety Inc  0.76 $ 1,946.916  Millions$ 2,568.362  Millions
Harmony Biosciences Holdings inc   0.75 $ 960.191  Millions$ 1,281.189  Millions
Novocure Limited  0.75 $ 699.193  Millions$ 937.159  Millions
Verrica Pharmaceuticals Inc   0.74 $ 30.321  Millions$ 40.707  Millions
Staar Surgical Co  0.74 $ 339.590  Millions$ 458.591  Millions
Adapthealth Corp   0.74 $ 3,226.709  Millions$ 4,366.244  Millions
Delcath Systems Inc   0.74 $ 94.058  Millions$ 127.446  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.